Tag: BusinessWeek

Posted on

Cost of Asthma Attacks Part of Math Behind Obama’s Carbon-Cutting Argument – Businessweek


Rappler

Cost of Asthma Attacks Part of Math Behind Obama's Carbon-Cutting Argument
Businessweek
Instead of added jobs or more spending to develop alternative energy sources, a majority of the benefits are calculated in terms of fewer illnesses, less health-care spending and more productive individuals. An asthma attack averted, for example, is …
New pollution rules will reduce asthma, heart attacksGlobalPost
Obama: My new EPA regs will prevent 'up to 100000 asthma attacks'Investor’s Business Daily
Obama heralds health benefits of climate plan to cut power plant emissionsThe Guardian
Rappler
all 3,814 news articles »

View full post on asthma – Google News

Posted on

Fast Foods Linked to Asthma, Eczema in Children: Study – Businessweek


The Sun

Fast Foods Linked to Asthma, Eczema in Children: Study
Businessweek
Teens who ate three or more weekly servings had a 39 percent increased chance of developing severe asthma, while younger children had a 27 percent higher risk, according to a study of 319,000 teens in 51 countries and 181,000 children ages 6 and 7 in …
Junk food link to kids' asthmaThe Sun
Junk food ups asthma, eczema risk in kidsTimes of India
Fast-food 'linked to childhood asthma and eczema'BBC News
Nursing in Practice –Press Trust of India
all 15 news articles »

View full post on asthma – Google News

Posted on

Glaxo starting late-stage study of asthma drug – Businessweek

Glaxo starting late-stage study of asthma drug
Businessweek
British drugmaker GlaxoSmithKline PLC said Monday that it is starting two late-stage patient studies of an experimental biologic drug as an add-on treatment for patients with severe, uncontrolled asthma. Both studies will compare the safety and …
GlaxoSmithKline starts final-stage tests on severe asthma drugFox News
GSK Begins Phase lll Program for Mepolizumab in Severe Refractory AsthmaFox Business
GSK starts final-stage tests on severe asthma drugWHTC
PipelineReview.com (press release)
all 18 news articles »

View full post on asthma – Google News

Posted on

FDA to rule on Glaxo-Theravance lung drug by May – Businessweek

FDA to rule on Glaxo-Theravance lung drug by May
Businessweek
The companies have asked the FDA to approve Breo as a treatment for chronic obstructive pulmonary disease, and they want the European Medicines Agency to approve the drug as a treatment for COPD and asthma. The companies added that on Tuesday …
GSK and Theravance Announce FDA Acceptance of FF/VI New Drug Application …NASDAQ
GlaxoSmithKline, Theravance say FDA Accepts FF/VI NDA Submission For COPDRTT News
GSK and Theravance make progress in FDA review of key COPD drugFierceBiotech

all 24 news articles »

View full post on asthma – Google News

Posted on

Synairgen in Drug Partnership Talks After Study Results – Businessweek

Synairgen in Drug Partnership Talks After Study Results
Businessweek
Synairgen Plc (SNG) is in talks with potential partners following the results of a study of an experimental medicine targeting infections that trigger asthma attacks, Chief Executive Officer Richard Marsden said. Synairgen is speaking with larger …
New drug 'stops common cold asthma deaths'Hayling Islander

all 3 news articles »

View full post on asthma – Google News

Posted on

Pfizer, Boehringer’s Drug Helped to Delay Asthma Attacks – Businessweek

Pfizer, Boehringer's Drug Helped to Delay Asthma Attacks
Businessweek
A lung drug from Boehringer Ingelheim GmbH and Pfizer Inc. (PFE) helped delay severe episodes in asthma patients, researchers said today in two studies that may result in broader use of the medicine. Spiriva, known chemically as tiotropium, cut the …
First Phase III Data for Tiotropium in Symptomatic Asthma Patients Treated …Sacramento Bee
Phase III results: tiotropiumA Respimat® significantly reduces exacerbations …Financial Post

all 13 news articles »

View full post on asthma – Google News

Posted on

Glaxo’s Experimental Drug Halves Asthma Attacks in Study – Businessweek


Telegraph.co.uk

Glaxo's Experimental Drug Halves Asthma Attacks in Study
Businessweek
Among 621 participants with severe asthma, after a year of treatment, the rate of attacks requiring oral corticosteroids, emergency room visits or hospitalizations was about half for those taking one of three monthly doses of the drug, called …
Experimental Drug May Cut Severe Asthma Attacks: StudyU.S. News & World Report
GSK drug halves attacks in hard-to-treat asthmaChicago Tribune
Experimental drug halves attacks in hard-to-treat asthmaFox News
Telegraph.co.uk
all 34 news articles »

View full post on asthma – Google News

Posted on

Watson gets FDA approval for generic asthma drug – Businessweek

Watson gets FDA approval for generic asthma drug
Businessweek
PARSIPPANY, N.J. (AP) — Generic drugmaker Watson Pharmaceuticals Inc. said Wednesday it received U.S. approval for its generic version of Pulmicort, an inhalable drug used to treat cough and breathing problems caused by asthma and lung disease.
FDA approves Watson asthma genericDrug Store News
Watson's Generic Version of Pulmicort RESPULES® Receives FDA ApprovalMarketWatch (press release)

all 13 news articles »

View full post on asthma – Google News